Spinal compression due to burkitt lymphoma in a newly diagnosed HIV-infected child

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 4, 2009, Pages 252-255

  Stefan, Daniela Cristina ^a,b   Van Toorn, Ronald ^a   Andronikou, Savvas ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

HIV related Burkitt lymphoma; Spinal cord compression

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CHILD; DRUG MEGADOSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; SPINAL CORD COMPRESSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PARAPLEGIA; PATHOLOGY; RADICULOPATHY; SPINAL CORD TUMOR; VERTEBRA;

BURKITT LYMPHOMA; CHILD; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PARAPLEGIA; POLYRADICULOPATHY; SPINAL CORD COMPRESSION; SPINAL CORD NEOPLASMS; THORACIC VERTEBRAE;

EID: 65349121447     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31818c918a     Document Type: Article

References (22)

1. Preciado MV, Fallo A, Chabay P, et al. Epstein Barr Virus associated lymphoma in HIV infected children. Path Res Pract. 2002;198:327-332.
2. Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007;60:1365-1372.
3. CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. http://www.cdc.gov/mmwr/preview/ mmwrhtml/00018871.htm Accessed: 2008-08-23.
4. Petruckevitch A, Del Amo J, Philips A, et al. Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London. AIDS. 1998;12:1007-1013.
5. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for Non-Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405-408.
6. International Collaboration on HIV and cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000;92:1823-1830.
7. Wessels G, Rossouw SH, Stefan DC, et al. Report on increased occurrence of Burkitt lymphoma in South Africa. Accepted for presentation at SIOP Africa, Tunis, 2008.
8. Link MP, Weinstein HJ. Malignant non-Hodgkin lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. 9. Daley MF, Partington MD, Kadan-Lottick N, et al. Primary epidural Burkitt lymphoma in a child: case presentation and literature review. Pediatr Hematol Oncol. 2003;20: 333-338.
9. Hesseling P, Broadhead R, Mansvelt E, et al. The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer. 2005;44: 245-250.
10. Husband DJ. Malignant spinal cord compression: prospective study of delays in referral and treatment. BMJ. 1998;317: 18-21.
11. Aysun S, Topcu M, Gunay M, et al. Neurologic features as initial presentations of childhood malignancies. Pediatr Neurol. 1994;10:40-43.
12. Matsubara H, Watanabe K, Sakai H, et al. Rapid improvement of paraplegia caused by epidural involvements of Burkitt's lymphoma with chemotherapy. Spine. 2004;29:E4-E6.
13. Dechambenoit G, Piquemal M, Giordano C, et al. Spinal cord compression resulting from Burkitt's lymphoma in children. Childs Nerv Syst. 1996;12:210-214.
14. De Bernardi B, Pianca C, Pistamiglio P, et al. Neuroblastoma with symptomatic cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol. 2001;19:183-190.
15. Bouffet E, Marec-Berard P, Thiesse P, et al. Spinal cord compression by secondary epi- and intradural metastases in childhood. Childs Nerv Syst. 1997;13:383-387.
16. Blinder VS, Chadburn A, Furman RR, et al. Improving Outcomes for Patients with Burkitt Lymphoma and HIV. AIDS Patient Care STD. 2008;22:175-189.
17. Mounier N, Spina M, Gisselbrecht C. Modern management of non-Hodgkin lymphoma in HIV-infected patients. Br J Haematol. 2006;136:685-698.
18. Pilecki B, Kopiec P, Zajusz A, et al. Hyperfractionated radiotherapy for Burkitt-type lymphoma. Radiobiological aspects. Neoplasma. 1991;38:609-615.
19. Watterson J, Toogood I, Nieder M, et al. Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer. 1994;74:3034-3041.
20. Michael JM, Lavin MF, Watters DJ. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 1997;57:3600-3605.
21. Sinclair AJ, Jacquemin MG, Brooks L. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Virology. 1994;199:339-353.
22. Bird CC, Waddell AW, Robertson AM, et al. Cytoplasmic receptor levels and glucocorticoid response in human lympho-blastoid cell lines. Br J Cancer. 1975;32:700-707.